Use of exercise for treatment of chronic fatigue syndrome.

K K McCully, S A Sisto, B H Natelson
Author Information
  1. K K McCully: Department of Medicine, Medical College of Pennsylvania, USA.

Abstract

Chronic fatigue syndrome (CFS) is a condition that results in moderate to severe disability, the primary feature of which is fatigue of unknown origin. There is a lot of interest in classifying, characterising and treating patients with CFS. Currently, the two major theories of a medical cause of CFS are viral infection and immune dysregulation. Patients report critical reductions in levels of physical activity, and many experience 'relapses' of severe symptoms following even moderate levels of exertion. Despite this, most studies report CFS patients to have normal muscle strength and either normal or slightly reduced muscle endurance. Histological and metabolic studies report mixed results: CFS patients have either no impairment or mild impairment of mitochondria and oxidative metabolism compared with sedentary controls. Current treatments for CFS are symptom-based, with psychological, pharmacological and rehabilitation treatments providing some relief but no cure. Immunological and nutritional treatments have been tried but have not provided reproducible benefits. Exercise training programmes are thought to be beneficial (if 'relapses' can be avoided), although few controlled studies have been performed. CFS is a long-lasting disorder that can slowly improve with time, but often does not. Further studies are needed to better understand the multiple factors that can cause chronic fatigue illness, as well as the effect that exercise training has on the symptoms of CFS.

References

  1. J Med Virol. 1994 Jan;42(1):42-6 [PMID: 8308519]
  2. Lancet. 1984 Jun 23;1(8391):1367-9 [PMID: 6145831]
  3. N Engl J Med. 1988 Dec 29;319(26):1692-8 [PMID: 2849717]
  4. J Psychosom Res. 1995 Jan;39(1):31-7 [PMID: 7760301]
  5. Arthritis Rheum. 1994 Jun;37(6):801-7 [PMID: 8003051]
  6. Med Sci Sports Exerc. 1984 Dec;16(6):529-38 [PMID: 6392811]
  7. Rheum Dis Clin North Am. 1989 Feb;15(1):135-47 [PMID: 2644674]
  8. Chest. 1992 Dec;102(6):1716-22 [PMID: 1446478]
  9. Acta Neuropathol. 1991;83(1):61-5 [PMID: 1792865]
  10. Arch Fam Med. 1993 Feb;2(2):181-6 [PMID: 8275187]
  11. Lancet. 1995 May 27;345(8961):1333-8 [PMID: 7752755]
  12. Med Sci Sports Exerc. 1992 Jan;24(1):54-8 [PMID: 1548996]
  13. Arthritis Rheum. 1988 Sep;31(9):1135-41 [PMID: 3048273]
  14. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S73-83 [PMID: 2020805]
  15. Med J Aust. 1990 Nov 5;153(9):522-8 [PMID: 2233474]
  16. Ann Intern Med. 1992 Jan 15;116(2):103-13 [PMID: 1309285]
  17. Ann Intern Med. 1994 Dec 15;121(12):953-9 [PMID: 7978722]
  18. Arch Phys Med Rehabil. 1994 Nov;75(11):1217-22 [PMID: 7979932]
  19. South Med J. 1991 Oct;84(10):1192-6 [PMID: 1925717]
  20. Clin Infect Dis. 1994 Jan;18 Suppl 1:S136-41 [PMID: 8148441]
  21. Arch Intern Med. 1989 Nov;149(11):2501-3 [PMID: 2684076]
  22. J Neurol Neurosurg Psychiatry. 1988 Oct;51(10):1316-22 [PMID: 2852211]
  23. BMJ. 1992 Jul 18;305(6846):147-52 [PMID: 1515828]
  24. Muscle Nerve. 1994 Aug;17(8):835-41 [PMID: 8041390]
  25. Neurology. 1993 Jan;43(1):125-31 [PMID: 8423875]
  26. Drugs. 1989 Dec;38(6):855-62 [PMID: 2693044]
  27. J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):679-83 [PMID: 8509783]
  28. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S8-11 [PMID: 2020806]
  29. BMJ. 1990 Oct 27;301(6758):953-6 [PMID: 2249024]
  30. J Biomech. 1991;24 Suppl 1:153-61 [PMID: 1791175]
  31. Aust N Z J Med. 1985 Jun;15(3):305-8 [PMID: 3864422]
  32. Med Sci Sports Exerc. 1982;14(1):101-2 [PMID: 7070249]
  33. JAMA. 1988 Aug 19;260(7):929-34 [PMID: 3398197]
  34. Clin Infect Dis. 1994 Jan;18 Suppl 1:S11-5 [PMID: 8148436]
  35. Drugs. 1993 Oct;46(4):639-51 [PMID: 7506650]
  36. Am J Med. 1993 Feb;94(2):197-203 [PMID: 8430715]
  37. Scand J Rheumatol. 1995;24(1):34-7 [PMID: 7863276]
  38. Arthritis Rheum. 1991 Mar;34(3):264-9 [PMID: 1848429]
  39. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S45-52 [PMID: 1850543]
  40. Clin Infect Dis. 1994 Jan;18 Suppl 1:S28-31 [PMID: 8148449]
  41. Am J Med. 1990 Nov;89(5):554-60 [PMID: 2239975]
  42. Clin Infect Dis. 1994 Jan;18 Suppl 1:S62-7 [PMID: 8148455]
  43. J Neurol Neurosurg Psychiatry. 1993 Sep;56(9):993-8 [PMID: 8410041]
  44. Ciba Found Symp. 1993;173:6-16; discussion 16-22 [PMID: 8491107]
  45. J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):743-6 [PMID: 3039060]
  46. Br Med Bull. 1991 Oct;47(4):919-41 [PMID: 1794091]
  47. Chest. 1988 Nov;94(5):919-25 [PMID: 3180895]
  48. Lancet. 1991 Mar 30;337(8744):757-60 [PMID: 1672392]
  49. Arthritis Rheum. 1990 Feb;33(2):160-72 [PMID: 2306288]
  50. Acta Neurol Scand. 1990 Sep;82(3):209-16 [PMID: 2270749]
  51. J Clin Microbiol. 1990 Jun;28(6):1403-10 [PMID: 2166084]
  52. Lancet. 1988 Nov 19;2(8621):1191-2 [PMID: 2903396]
  53. Med Sci Sports Exerc. 1988 Aug;20(4):319-30 [PMID: 3050352]
  54. J Clin Immunol. 1993 Jan;13(1):30-40 [PMID: 8095270]
  55. Clin Infect Dis. 1994 Jan;18 Suppl 1:S142-6 [PMID: 8148442]
  56. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6714-8 [PMID: 6947247]
  57. Clin Infect Dis. 1994 Jan;18 Suppl 1:S154-6 [PMID: 8148444]
  58. Behav Res Ther. 1995 Jun;33(5):535-44 [PMID: 7598674]
  59. J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):38-43 [PMID: 7823065]
  60. Am J Med. 1990 Nov;89(5):561-8 [PMID: 2146875]
  61. BMJ. 1994 Mar 19;308(6931):756-9 [PMID: 8142830]
  62. Ann Intern Med. 1992 Aug 15;117(4):325-31 [PMID: 1322076]
  63. Am J Med. 1995 Feb;98(2):187-95 [PMID: 7847436]
  64. BMJ. 1988 Oct 22;297(6655):1014-7 [PMID: 3142592]
  65. Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S114-8 [PMID: 2020797]
  66. Med Sci Sports Exerc. 1992 Jan;24(1):26-9 [PMID: 1548992]
  67. Arch Intern Med. 1993 Dec 27;153(24):2759-65 [PMID: 8257251]

Grants

  1. AI-32247/NIAID NIH HHS

MeSH Term

Combined Modality Therapy
Exercise Therapy
Fatigue Syndrome, Chronic
Humans
Muscles
Treatment Outcome

Word Cloud

Created with Highcharts 10.0.0CFSfatiguestudiespatientsreporttreatmentscansyndromemoderateseverecauselevels'relapses'symptomsnormalmuscleeitherimpairmenttrainingchronicexerciseChronicconditionresultsdisabilityprimaryfeatureunknownoriginlotinterestclassifyingcharacterisingtreatingCurrentlytwomajortheoriesmedicalviralinfectionimmunedysregulationPatientscriticalreductionsphysicalactivitymanyexperiencefollowingevenexertionDespitestrengthslightlyreducedenduranceHistologicalmetabolicmixedresults:mildmitochondriaoxidativemetabolismcomparedsedentarycontrolsCurrentsymptom-basedpsychologicalpharmacologicalrehabilitationprovidingreliefcureImmunologicalnutritionaltriedprovidedreproduciblebenefitsExerciseprogrammesthoughtbeneficialavoidedalthoughcontrolledperformedlong-lastingdisorderslowlyimprovetimeoftenneededbetterunderstandmultiplefactorsillnesswelleffectUsetreatment

Similar Articles

Cited By